Cargando…
Polymeric Nanocarriers for Effective Synergistic Action of Sorafenib Tosylate and Gold-sensitized Gamma Radiation Against HepG2 Cells
PURPOSE: One of the key parameters towards effective and synergistic combinatorial anticancer therapeutic models is the nanocarrier. Nearly all previous studies have been limited to one nanocarrier for one drug. However, a comparative study on two polymeric nanocarriers for the same drug against the...
Autores principales: | Sukkar, Firas, Shafaa, Medhat, El-Nagdy, Mohamed, Darwish, Wael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711844/ https://www.ncbi.nlm.nih.gov/pubmed/34992367 http://dx.doi.org/10.2147/IJN.S331909 |
Ejemplares similares
-
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells
por: Taha, Amna Mohamed, et al.
Publicado: (2022) -
Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium Conjugation Techniques
por: Feczkó, Tivadar, et al.
Publicado: (2019) -
PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial-mesenchymal transition
por: Liu, Hongyu, et al.
Publicado: (2019) -
Impact of Crystal Habit on the Dissolution Rate and In Vivo Pharmacokinetics of Sorafenib Tosylate
por: Phan, Chi Uyen, et al.
Publicado: (2021) -
High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo
por: Xiao, Yinzong, et al.
Publicado: (2017)